DRL logo

DRL Biospecimen Purchase and Material Transfer Terms

Version 2.1 | Last updated 16 November 2026

1 Parties and scope

These Terms are between Diagnostics Research Laboratory – DRL LLC, doing business as DRL, at1124 West Carson Street, MRL Building, 3rd Floor, Torrance, CA 90502, USA (DRL), and the legalorganization identified in the Order (Buyer). They apply to biospecimens, cells, organoids andassociated research materials supplied under an Order. Standalone services, subscriptions and customdevelopment require separate written terms. Consumer purchases and personal use are not permitted.The individual accepting these Terms represents that they are at least 18 and authorized to bind Buyer.Buyer is responsible for its personnel and permitted recipients. DRL may verify institutional eligibility,intended use and required approvals before accepting or shipping an Order.

2 Definitions

Original Materials means the physical materials supplied by DRL. Replicates means unmodifiedprogeny, cultures or copies retaining the essential characteristics of Original Materials. ModifiedMaterials means physical materials created by Buyer that contain or incorporate Original Materials orReplicates. Materials means all three categories. Research Results means data, analyses, discoveriesand inventions generated by Buyer, excluding Materials, Associated Data and either party’s pre-existingintellectual property.

Associated Data means the accompanying specimen and donor-related information supplied by DRL.Use Restrictions means specimen-specific consent, ethical, contractual or legal restrictions disclosedbefore acceptance of the Order. Specifications means the expressly agreed product characteristics,quantities and quality criteria identified in the Order and incorporated product specification. A certificateof analysis reports lot-specific testing and does not amend agreed Specifications unless expresslyaccepted by Buyer.

3 Orders and document priority

An order submission is an offer. An automated receipt or payment notification is not acceptance. AnOrder becomes binding only when DRL issues an express acceptance identifying the products,Specifications, price, delivery charges and Use Restrictions. DRL may reject an offer and release orrefund the related payment. Material changes require Buyer’s express agreement; silence is notacceptance.Priority is: a signed negotiated agreement; expressly agreed Order-specific deviations; these Terms;then incorporated Specifications. Use Restrictions cannot be overridden by commercial terms.Additional or conflicting terms in Buyer purchase orders or portals do not apply unless expressly signedby DRL. DRL will retain the applicable version and incorporated documents.

Commercial and delivery terms

4 Pricing and payment

Prices are in US dollars. Taxes, freight, cold-chain packaging, customs charges and duties areexcluded unless expressly included. All DRL charges must be shown at checkout or expressly acceptedin a quotation before capture of the related amount. Buyer is responsible for applicable transactiontaxes, except taxes on DRL income, and must provide valid exemption documentation before invoicing.DRL authorizes the card at checkout and captures payment after accepting the Order and confirmingavailability, before shipment. If authorization expires, DRL may request fresh authorization and delayshipment. Any different policy must be expressly agreed before payment. Card information is handledby the payment processor; DRL does not store full card numbers. Invoice or purchase-order paymentrequires prior written approval.

5 Cancellation and unavailable materials

Before DRL begins retrieval, aliquoting, processing or other Order-specific preparation, Buyer maycancel for a full refund. After preparation begins, cancellation requires DRL approval and Buyer mustpay reasonable, documented, nonrecoverable costs actually incurred or committed for that Order, notexceeding its price. No fixed percentage penalty applies. For prospective collection or custom work,cancellation milestones and charges must be agreed in a separate statement of work.

If DRL cannot supply conforming Materials, DRL will offer an agreed substitute or refund theundelivered portion and its allocable prepaid shipping charges. DRL will not substitute a donor, formator matched set without Buyer’s approval. Refunds will be initiated to the original payment method within 10 business days after approval, subject to lawful sanctions restrictions.

6 Shipping and allocation of risk

Buyer must provide a correct address, qualified receiving staff, suitable facilities and destination importpermits before shipment. DRL is responsible for export requirements applicable to DRL and appropriatepackaging for the agreed shipment. Buyer is the importer of record unless the Order expressly statesotherwise. International shipping terms and charges require written acceptance before dispatch.

Unless expressly varied in the Order, DRL bears transit loss or spoilage until delivery at the agreedaddress, including carrier delay not caused by Buyer. Buyer bears loss to the extent caused by itsincorrect information, missing permits, failure to receive an agreed delivery or improper handling afterreceipt. DRL remains responsible for its own packaging or documentation failures. Risk allocation underthis section prevails over the general force majeure clause. DRL’s sole obligation for transit loss orspoilage is the replacement or refund remedy in section 7.Title to the delivered physical Original Materials passes after delivery and full payment, subject to theuse and transfer restrictions in these Terms. No ownership of donors, personal information or third-party intellectual property is transferred. Delivery dates are estimates unless expressly guaranteed. DRL willnotify Buyer of material delays and cooperate to mitigate transit loss.

Quality and permitted use

7 Inspection and remedies

Buyer must promptly inspect deliveries and follow documented storage instructions. Notify DRL atinfo@drlus.com within two business days of visible shipping damage, thawing, shortage or incorrectmaterial, with reasonably available photos and logger records. Submit latent nonconformity claimswithin 15 days after discovery and no later than 90 days after delivery. DRL may decline claims notnotified within these periods. Nonwaivable legal rights remain unaffected.DRL may reasonably request relevant handling records and testing and will assess claims promptly andin good faith. Buyer must preserve evidence where safe, but must not ship biological materials backwithout written authorization. No remedy applies to defects caused by Buyer’s misuse, unapprovedprocessing or storage failure, or merely to lack of desired research outcomes.For confirmed nonconformity existing at delivery, DRL will, at its option, supply an equivalentreplacement acceptable to Buyer or refund the affected product price and allocable standard shippingcharges. If no agreed replacement is available within 30 days after confirmation, DRL will refund.Equivalence includes agreed donor-matching and other critical Specifications. These are the exclusivecontractual remedies for product nonconformity, subject to nonwaivable law and the separateobligations in section 15. No change-of-mind returns are accepted.

8 DRL representations

DRL represents that, at delivery, it has authority to supply Original Materials and Associated Data forthe agreed permitted use; maintains documented lawful sourcing and applicable consent or other lawfulauthorization supporting that use; has obtained or documented ethics approval where legally required;complies with laws applicable to its collection, processing and export activities; and supplies Materialsmaterially conforming to the agreed Specifications. Any reliance on a consent waiver or alternativelawful basis must be disclosed and accepted before the Order. No human fetal tissue or humanembryonic stem cells may be supplied under these standard Terms.

DRL will disclose material Use Restrictions before Order acceptance. On reasonable request, DRL willprovide available, relevant provenance attestations, redacted consent templates, ethics documentationand agreed quality records, subject to confidentiality, privacy and source restrictions. DRL does notundertake to disclose donor identities, keys or unrestricted copies of source records. If agreeddocumentation is unavailable, DRL will notify Buyer before accepting the Order and obtain Buyer’sagreement to any proposed change.

9 Research use and biosafety

Buyer may use Materials and Associated Data only for lawful internal academic or commercial research

within the Use Restrictions. No administration to humans, transplantation, clinical diagnosis, patient-care decisions, food use or therapeutic use is permitted. Buyer must obtain approvals applicable to its

own research and treat all Materials as potentially infectious regardless of test results. Infectious-agenttesting, where performed, does not guarantee the absence of pathogens. Buyer is responsible for safereceipt, storage, handling and disposal by trained personnel.

Materials data and intellectual property

10 Transfers and commercial exploitation

Buyer must not sell, sublicense, distribute or supply Materials as products, offer access to them as arepository, or use them to provide services to unrelated third parties without DRL’s prior writtenagreement. Internal commercial research, including drug discovery, is permitted subject to UseRestrictions. Commercialization of Research Results is permitted provided it does not transfer Materialsor Associated Data or violate these Terms. No separate DRL royalty is imposed by these Terms onsuch permitted commercialization.

Buyer may transfer the minimum necessary Materials or Associated Data to a contractor or collaboratorsolely performing the agreed research on Buyer’s behalf, if permitted by Use Restrictions and law,under a prior written agreement no less protective than these Terms. Buyer remains responsible for thatrecipient’s compliance, must retain recipient and transfer records, and must prohibit onward transfer.Independent collaborator research, affiliate transfers outside the agreed project and resale requirewritten DRL approval.

11 Results and retained rights

As between DRL and Buyer, Buyer owns its Research Results. Each party retains its pre-existingintellectual property. Ownership of Modified Materials does not remove restrictions on incorporatedOriginal Materials and Replicates. No implied license to DRL patents, proprietary methods or third-partyrights is granted. These Terms do not determine or waive donor or third-party rights that DRL has noauthority to waive.

Buyer may publish Research Results subject to donor privacy, Use Restrictions and protection of DRLconfidential information; no general DRL publication veto applies. Publication does not authorizerelease of Associated Data or identifiable genomic information. Training models for Buyer’s internalresearch is permitted only within applicable Use Restrictions. Public release, sale or licensing ofAssociated Data, donor-level datasets or models that expose or permit recovery of such data requires aseparate written agreement. Neither party may imply endorsement or use the other’s logo withoutconsent; factual source attribution is permitted.

12 Data protection and confidentiality

DRL will disclose the applicable data classification and permitted data use before supply. Where HIPAAde-identification is represented, DRL will use an applicable recognized method. Coded orpseudonymized information is not represented as anonymous under all laws. Any required data transferagreement, lawful international transfer mechanism or additional privacy terms must be completedbefore transfer; these Terms do not replace them.Buyer must not identify, re-identify or contact donors, request linkage keys, or combine information withexternal datasets for identification. Buyer must restrict access to authorized personnel, implementappropriate security, and promptly notify DRL, without undue delay and in any event within 48 hoursafter awareness, of unauthorized access, disclosure or identification involving supplied data. Each partywill cooperate on containment and legally required notifications; mandatory shorter deadlines prevail.

Each party will protect the other’s nonpublic information using reasonable care and use it only for thetransaction or permitted research. Disclosure to bound personnel, contractors, advisers and carriers ispermitted as needed. Exceptions apply to information lawfully public, previously known, independentlydeveloped or lawfully received without restriction. Legally required disclosure is permitted with priornotice where lawful. Confidentiality lasts five years after disclosure; trade secrets and donor-relateddata remain protected while legally or contractually required. DRL handles account and checkoutinformation under the Privacy Notice made available on drlus.com and linked at checkout.

Liability and protective procedures

13 Withdrawal restrictions and suspension

If DRL learns of a consent withdrawal, legal restriction or sourcing defect requiring action for identifiableaffected inventory or data, DRL will notify Buyer with reasonably available instructions. Buyer mustsuspend affected use and implement legally required or consent-required restrictions, deletion ordestruction, including through permitted recipients, and certify completion on request. Retention ofexisting results, publications, mandatory records and inaccessible backups is permitted only to theextent lawful and consistent with applicable consent; retained copies remain protected and unavailablefor new research.

No party promises retrieval of irreversibly anonymized, consumed or untraceable material. DRL will usereasonable efforts to identify affected distributed lots. For unused affected Materials that can no longerlawfully be used, DRL will offer an agreed replacement or refund of their allocable price, subject tosection 14. This does not limit liability that cannot lawfully be limited.

DRL may suspend delivery or affected use immediately where reasonably necessary for safety, privacyor legal compliance, and terminate an Order for a material breach not cured within 15 days after notice,or immediately for an incurable breach. Buyer must cease unauthorized use and, where required,destroy affected Materials and data and obtain recipient certifications. Properly generated ResearchResults may be retained only as permitted above. Refunds for DRL nonperformance remain governedby sections 5–7; suspension does not create a right to keep unearned payments.

14 Warranty disclaimer and liability limits

EXCEPT FOR THE EXPRESS REPRESENTATIONS AND SPECIFICATIONS IN THESE TERMS,MATERIALS AND ASSOCIATED DATA ARE PROVIDED AS IS. TO THE MAXIMUM EXTENTPERMITTED BY LAW, DRL DISCLAIMS OTHER WARRANTIES, INCLUDING MERCHANTABILITY,FITNESS FOR A PARTICULAR PURPOSE AND NONFRINGEMENT. NATURAL BIOLOGICALVARIABILITY AND A PARTICULAR RESEARCH OUTCOME ARE NOT WARRANTED. THISDISCLAIMER DOES NOT NEGATE AN EXPRESS WARRANTY OR NONWAIVABLE RIGHT.

To the extent permitted by law, neither party is liable for indirect, incidental, special or consequentialdamages, lost profits or lost research time. DRL’s aggregate liability arising from an Order, under anylegal theory and including its section 15 obligations, shall not exceed the amounts paid or payable toDRL under that Order. Defense costs and settlements count toward this cap; related claims do notmultiply it.

The foregoing exclusions and cap do not apply to fraud, willful misconduct, gross negligence or liabilitythat cannot lawfully be excluded or limited. The mutual consequential-damages exclusion does not

restrict Buyer’s indemnity obligations or damages arising from Buyer’s unauthorized transfer, re-identification or misuse of confidential information. Buyer’s payment obligations are not excused. No

double recovery is permitted.

15 Third party claims

Buyer will defend and indemnify DRL and its officers and employees against third-party claims,reasonable defense costs and awarded damages to the extent caused by Buyer’s or its recipients’breach, unlawful use or negligent handling of Materials or data. DRL will defend and indemnify Buyer

against third-party claims to the extent caused by DRL’s breach of its authority-to-supply or lawful-sourcing representations in section 8, subject expressly to section 14. Neither party indemnifies the

other for the other’s fault or unauthorized use.

The indemnified party must promptly notify the other, cooperate at the indemnifying party’s reasonableexpense and allow control of the defense by qualified counsel. Late notice reduces obligations only tothe extent prejudicial. No settlement may admit fault, impose nonmonetary obligations or fail to releasethe indemnified party without its consent, not unreasonably withheld. Conflicts of interest andexhaustion of any cap must be addressed by prompt notice and an orderly defense transition withoutprejudicing either party’s rights.

Administration and acceptance

16 Compliance and force majeure

Each party must comply with sanctions, export controls and anti-bribery rules applicable to it. Buyermust not divert Materials or data to prohibited recipients, destinations or uses. DRL may suspend orcancel unlawful transactions and will refund unearned amounts only through a lawful route. Neitherparty is excused from legal compliance by these Terms.

Events beyond reasonable control excuse affected delays while the affected party promptly notifies theother and uses reasonable mitigation efforts. Payment for delivered conforming goods remains due.Section 6 controls transit risk. If an event prevents delivery for more than 30 days, either party maycancel the undelivered portion with refund of allocable prepaid amounts, except approvednonrecoverable custom-work costs under a separate signed agreement.

17 Governing law and disputes

California law governs without its conflicts rules. The UN Convention on Contracts for the InternationalSale of Goods is excluded. Parties will attempt good-faith resolution for 30 days after written notice.Subject to nonwaivable law, disputes shall be brought exclusively in state or federal courts in LosAngeles County, California. Either party may seek urgent protective relief in a court of competentjurisdiction without waiting for that period. No provision waives mandatory statutory rights.

18 General provisions and notices

These Terms and the documents incorporated under section 3 constitute the agreement. The PrivacyNotice explains account-data practices and does not modify product warranties or remedies.Amendments to an accepted Order require express written agreement; subsequently posted termsapply only to future Orders. Electronic acceptance may establish agreement, subject to applicable law.

Legal notices go to info@drlus.com and Buyer’s designated Order email; notices are effective onacknowledged receipt or the next business day after successful transmission without a delivery-failurenotice. Mandatory service-of-process rules are unaffected.Neither party may assign this agreement without the other’s consent, not unreasonably withheld, exceptthat DRL may assign to an affiliate, and either party may assign to a successor acquiring substantiallyall relevant business assets and assuming its obligations, where lawful and consistent with Use

Restrictions. Assignment does not authorize a material or data transfer otherwise prohibited.Severability, nonwaiver and independent-contractor principles apply. Sections governing accruedpayment, use restrictions, data protection, retained rights, remedies, indemnity, liability and disputeresolution survive as necessary to give them effect. There are no third-party beneficiaries exceptindemnified persons expressly identified in section 15.

19 Checkout acceptance

I have read and agree to the DRL Biospecimen Purchase and Material Transfer Terms, version 2.1, andthe Order-specific Use Restrictions. I am authorized to bind the organization identified in this Order. Iconfirm that the Materials and Associated Data will be used only for permitted research and not foradministration to humans, clinical diagnosis or patient care.

Contact: Diagnostics Research Laboratory – DRL LLC | 1124 West Carson Street, MRL Building, 3rdFloor, Torrance, CA 90502, USA | info@drlus.com | +1 442-224-3375 | drlus.com

DRL logo
Contract research organization, which provides solutions for pharma and diagnostics companies, including consulting, cancer models development, and various assays for drug development.
contact
1124 West Carson
St, MRL Building, 3rd Fl, Torrance,
CA 90502, USA
Call: +1 442-224-3375
E-mail: Info@drlus.com
©2026 DRL US. All Rights Reserved.